Search

Your search keyword '"Claire M Mach"' showing total 9 results
Start Over "Claire M Mach" Database Gale General OneFile
9 results on '"Claire M Mach"'

1. 424B3: SignPath Pharma, Inc

Subjects
Business, general
Abstract

(EDGAR Online via COMTEX) -- signpath.htm -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- PROSPECTUS Registration Statement No. 333-198110 Filed Pursuant to Rule 424(b)(3) SIGNPATH PHARMA INC. 23,387,488 Shares of common stock This prospectus relates to [...]

Published
2015

2. 424B3: SignPath Pharma, Inc

Subjects
Business, general
Abstract

(EDGAR Online via COMTEX) -- signpath.htm -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- PROSPECTUS Registration Statement No. 333-198110 Filed Pursuant to Rule 424(b)(3) SIGNPATH PHARMA INC. 23,387,488 Shares of common stock This prospectus relates to [...]

Published
2015

3. S-1/A: SignPath Pharma, Inc

Subjects
Business, general
Abstract

(EDGAR Online via COMTEX) -- signpath.htm -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- As filed with the Securities and Exchange Commission on January 27, 2015 Registration No. 333-198110 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, [...]

Published
2015

4. S-1/A: SignPath Pharma, Inc

Subjects
Business, general
Abstract

(EDGAR Online via COMTEX) -- signpath.htm -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- As filed with the Securities and Exchange Commission on January 13, 2015 Registration No. 333-198110 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, [...]

Published
2015

5. S-1/A: SignPath Pharma, Inc

Subjects
Business, general
Abstract

(EDGAR Online via COMTEX) -- signpath.htm -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- As filed with the Securities and Exchange Commission on December 12, 2014 Registration No. 333-198110 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, [...]

Published
2014

6. S-1/A: SignPath Pharma, Inc

Subjects
United States. Securities and Exchange Commission, United States. Food and Drug Administration, Business, general, University of Texas. M.D. Anderson Cancer Center
Abstract

(EDGAR Online via COMTEX) -- signpath.htm -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- As filed with the Securities and Exchange Commission on November 3, 2014 Registration No. 333-198110 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, [...]

Published
2014

7. S-1/A: SignPath Pharma, Inc

Subjects
United States. Securities and Exchange Commission, United States. Food and Drug Administration, Business, general, University of Texas. M.D. Anderson Cancer Center
Abstract

(EDGAR Online via COMTEX) -- signpath.htm -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- As filed with the Securities and Exchange Commission on October 23, 2014 Registration No. 333-198110 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, [...]

Published
2014

8. S-1/A: SignPath Pharma, Inc

Subjects
United States. Securities and Exchange Commission, United States. Food and Drug Administration, Business, general, University of Texas. M.D. Anderson Cancer Center
Abstract

(EDGAR Online via COMTEX) -- signpath.htm -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- As filed with the Securities and Exchange Commission on September 9, 2014 Registration No. 333-198110 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, [...]

Published
2014

9. S-1: SignPath Pharma, Inc

Subjects
United States. Securities and Exchange Commission, United States. Food and Drug Administration, Business, general, University of Texas. M.D. Anderson Cancer Center
Abstract

(EDGAR Online via COMTEX) -- signpath.htm -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- As filed with the Securities and Exchange Commission on August 12, 2014 Registration No. 333-______ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, [...]

Published
2014

Catalog

Books, media, physical & digital resources
See catalog results